Applications of Crispr-Cas9 in Mitigating Cellular Senescence and Age-Related Disease Progression Publisher Pubmed



A Azani ALIREZA ; M Sharafi MALIHE ; R Doachi REYHANEH ; S Akbarzadeh SAMA ; P Lorestani PARSA ; A Haji Kamanaj Olia ARASH ; Z Zahed ZAHRA ; H Gharedaghi HOSSEIN ; H Ghasrsaz HANIYEH ; H Foroozand HOSSEIN
Source: Clinical and Experimental Medicine Published:2025

Abstract

Aging is a multifaceted process influenced by many elements. During cell division, the repetitive DNA sequences at the ends of chromosomes called telomeres protect them from degradation. Telomeres shorten alongside each cell division, eventually contributing to cellular senescence and aging. Telomerase as an enzyme has a role in the maintenance of telomere length. Reduced function of telomerase is linked to acceleration of aging and age-related diseases. By affecting cellular function, mutations in particular genes can cause aging. Genes involved in DNA repair, cellular metabolism, and inflammation play the key roles in this process. Accumulated mutations result in cellular dysfunction and age-related diseases over time. Epigenetic changes are the modifications that impact gene expression without altering the DNA sequence. Lifestyle factors (diet, exercise, stress) and environmental influences (toxins, trauma) can cause epigenetic alterations. DNA methylation as well as histone modifications are examples of epigenetic alterations. They influence how cells work and are essential to the aging process. Understanding these molecular mechanisms is essential for developing interventions to promote healthy aging and prevent age-related diseases. This paper explores the potential of CRISPR/Cas9 as a gene-editing tool to target these mechanisms and mitigate age-related conditions, ultimately enhancing longevity and quality of life. © 2025 Elsevier B.V., All rights reserved.